Stroke Clinical Trials in Salt Lake City, Utah
9 studies are recruiting for stroke in Salt Lake City, Utah right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Telerehabilitation In The Home After Stroke
The purpose of this research study is to evaluate whether telerehabilitation targeting arm movement, when added to usual care, improves arm function and reduces global disability after stroke, compared to usual care alone. Patients with arm weakness due to stroke that happened in the past 90-150 da…
- Stage
- Not phased
- Ages
- 18 to 80
- Site
- University of Utah Health, Salt Lake City, Utah
- Locations
- 27 in total
- Run by
- University of California, Los Angeles
-
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
TESTED will compare the risks and benefits of endovascular thrombectomy (EVT) to medical management (no EVT) in ischemic stroke patients who have a blockage in one of the large blood vessels in the brain and have a moderate-to-severe disability prior to their stroke.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Utah, Salt Lake City, Utah
- Locations
- 35 in total
- Run by
- University of Cincinnati
-
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospective dataset of clinical, tra…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Utah Healthcare, Salt Lake City, Utah
- Locations
- 45 in total
- Run by
- Yale University
-
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator education and training and transferability of trial experience to a post-market setting.
- Stage
- Not phased
- Ages
- 18 to 70
- Site
- St. Marks Hospital, Salt Lake City, Utah
- Locations
- 45 in total
- Run by
- W.L.Gore & Associates
-
Digital Technology-Informed Stroke Rehabilitation
The goal of this study is to determine the effects of lab and home-based technology guidance during movement training post-stroke. The study will compare movement training informed by lab-based technology to training delivered with technology at home. The main questions it aims to answer are: * How…
- Stage
- Not phased
- Ages
- 30 to 85
- Site
- Kennecott Mechanical Engineering Building, Salt Lake City, Utah
- Run by
- University of Utah
-
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated c…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- University of Utah, Salt Lake City, Utah
- Locations
- 106 in total
- Run by
- Icahn School of Medicine at Mount Sinai
-
Stroke Thrombectomy and Aneurysm Registry
This international multi-center registry is used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an artery, abnormal tangling of blood ves…
- Stage
- Not phased
- Ages
- 1 to 120
- Site
- University of Utah, Salt Lake City, Utah
- Locations
- 63 in total
- Run by
- Medical University of South Carolina
-
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
Durable left ventricular assist devices (dLVAD) have been increasingly utilized since the mid to late 1990s, with an uptick of utility starting in 2010 following expanded indications for therapy to not only include a bridge to transplantation strategy, but also for those individuals who suffer from…
- Stage
- Not phased
- Ages
- 18 to 100
- Site
- University of Utah, Salt Lake City, Utah
- Locations
- 7 in total
- Run by
- International Consortium of Circulatory Assist Clinicians
-
Cycle and Stroke With Biofeedback for Power Symmetry
To determine changes in power symmetry, gait symmetry, and functional outcomes for participants' poststroke (Inpatient Rehabilitation Facility) after participating in an intervention using a recumbent cycle with power biofeedback (BFB). To determine how this intervention can impact gait asymmetry, …
- Stage
- Not phased
- Ages
- 18 to 70
- Site
- University Health, Neilsen Rehabilitation Hospital, Salt Lake City, Utah
- Run by
- University of Utah
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.